![Axel Bouchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Axel Bouchon
Fundador en
BrainLuxury, Inc.
.
Perfil
Axel Bouchon is the founder of BrainLuxury, Inc., founded in 2020, serving as Chairman since 2020.
Dr. Bouchon is the founder of Matter Neuroscience, Inc., founded in 2019, serving as Chief Executive Officer since 2019.
Current jobs include Chief Executive Officer at AMLOne UG (haftungsbeschränkt) since 2016, Chairman at Brain Games Corp.
since 2020, and Venture Partner at ARCH Venture Partners LLC since 2021.
Former jobs include Chief Executive Officer at Moderne Capital LLC, Non-Executive Director at Brii Biosciences Ltd. (China) from 2021 to 2022, Head-Lifescience Center at Bayer AG from 2015 to 2019, and Member at Moderna, Inc. Education includes a doctorate degree from Eberhard Karls Universität Tübingen, conferred in 2002.
Cargos activos de Axel Bouchon
| Empresas | Cargo | Inicio |
|---|---|---|
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Inversor de Capital Privado | 01/12/2021 |
BrainLuxury, Inc.
 BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and commercializes nutritional brain supplements products | Fundador | 01/01/2020 |
Brain Games Corp.
 Brain Games Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in neuroscience and tech to help people track and boost their happiness | Presidente | 01/01/2020 |
AMLOne UG (haftungsbeschränkt) | Director Ejecutivo | 01/07/2016 |
Matter Neuroscience
 Matter Neuroscience Packaged SoftwareTechnology Services Develops mobile application for neurological reward systems | Director Ejecutivo | 01/01/2019 |
Antiguos cargos conocidos de Axel Bouchon.
| Empresas | Cargo | Fin |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Director/Miembro de la Junta | 30/09/2022 |
| BAYER AG | Corporate Officer/Principal | 01/01/2019 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Moderne Capital LLC
 Moderne Capital LLC Investment ManagersFinance Moderne Ventures invests in companies located in the United States with revenues of USD 1 - 30 million. The firm focuses across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Director Ejecutivo | - |
Formación de Axel Bouchon.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
34
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners invests in disruptive science companies located in the United States. The firm target companies operating in the fields of biotechnology and technology sectors. It provides financing for early stage capital requirements with a minimum investment size of $0.05 million and also makes co-investments. | Finance |
Eberhard Karls Universität Tübingen
 Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderne Capital LLC
Moderne Capital LLC Investment ManagersFinance Moderne Ventures invests in companies located in the United States with revenues of USD 1 - 30 million. The firm focuses across a broad range of sectors and industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Brii Biosciences Ltd. (China)
 Brii Biosciences Ltd. (China) BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Brain Games Corp.
Brain Games Corp. Miscellaneous Commercial ServicesCommercial Services Specializes in neuroscience and tech to help people track and boost their happiness | Commercial Services |
BrainLuxury, Inc.
BrainLuxury, Inc. Pharmaceuticals: OtherHealth Technology Develops, manufactures and commercializes nutritional brain supplements products | Health Technology |
AMLOne UG (haftungsbeschränkt) | |
Matter Neuroscience
Matter Neuroscience Packaged SoftwareTechnology Services Develops mobile application for neurological reward systems | Technology Services |
- Bolsa de valores
- Insiders
- Axel Bouchon
